These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 4439870)
1. The pharmacokinetics of acetanilide and of diphenylhydantoin sodium. Cunningham JL; Bullen MF; Evans DA Eur J Clin Pharmacol; 1974 Oct; 7(6):461-6. PubMed ID: 4439870 [No Abstract] [Full Text] [Related]
2. Urinary D-glucaric acid excretion and acetanilide pharmacokinetics before and during diphenylhydantoin administration. Cunningham JL; Evans DA Eur J Clin Pharmacol; 1974 Aug; 7(5):387-91. PubMed ID: 4417891 [No Abstract] [Full Text] [Related]
3. Binding of 5,5-diphenylhydantoin and its major metabolite to human and rat plasma proteins. Conard GJ; Haavik CO; Finger KF J Pharm Sci; 1971 Nov; 60(11):1642-6. PubMed ID: 4943934 [No Abstract] [Full Text] [Related]
4. Letter: Comments on the determination of diphenylhydantoin. Wallace JE; Farquhar JK; Hamilton HE; Everhart BA Clin Chem; 1974 Apr; 20(4):515-6. PubMed ID: 4818210 [No Abstract] [Full Text] [Related]
5. Acetanilide and paracetamol pharmacokinetics before and during phenytoin administration: genetic control of induction? Cunningham JL; Evans DA Br J Clin Pharmacol; 1981 Jan; 11(6):591-5. PubMed ID: 7272175 [TBL] [Abstract][Full Text] [Related]
6. The metabolism of diphenylhydantoin (Dilantin) following once-daily administration. Buchanan RA; Kinkel AW; Goulet JR; Smith TC Neurology; 1972 Feb; 22(2):126-30. PubMed ID: 5061843 [No Abstract] [Full Text] [Related]
7. Pharmacokinetic study of a patient with diphenylhydantoin toxicity. Atkinson AJ; Shaw JM Clin Pharmacol Ther; 1973; 14(4):521-8. PubMed ID: 4198768 [No Abstract] [Full Text] [Related]
8. The acute effects of ethanol on acetanilide disposition in normal subjects, and in patients with liver disease. McKay J; Rawlings MD; Cobden I; James OF Br J Clin Pharmacol; 1982 Oct; 14(4):501-4. PubMed ID: 7138735 [TBL] [Abstract][Full Text] [Related]
9. Michaelis-Menten pharmacokinetics of diphenylhydantoin and application in the pediatric age patient. Chiba K; Ishizaki T; Miura H; Minagawa K J Pediatr; 1980 Mar; 96(3 Pt 1):479-84. PubMed ID: 7359247 [TBL] [Abstract][Full Text] [Related]
10. [A micromethod for the determination of diphenylhydantoin (phenhydan) in blood by high speed liquid chromatography (author's transl)]. Gauchel G; Gauchel FD; Birkofer L Z Klin Chem Klin Biochem; 1973 Jan; 11(1):35-8. PubMed ID: 4804141 [No Abstract] [Full Text] [Related]
11. Quantitative assay of 5,5-diphenylhydantoin (Dilantin) and 5-(p-hydroxyphenyl)-5-phenylhydantoin by gas-liquid chromatography. Chang T; Glazko AJ J Lab Clin Med; 1970 Jan; 75(1):145-55. PubMed ID: 5410494 [No Abstract] [Full Text] [Related]
12. Kinetics of diphenylhydantoin disposition in man. Suzuki T; Saito Y; Nishihara K Chem Pharm Bull (Tokyo); 1970 Feb; 18(2):405-11. PubMed ID: 5438584 [No Abstract] [Full Text] [Related]
13. The influence of diphenylhydantoin on primidone metabolism. Fincham RW; Schottelius DD; Sahs AL Arch Neurol; 1974 Mar; 30(3):259-62. PubMed ID: 4812960 [No Abstract] [Full Text] [Related]
14. Serum theophylline and phenytoin levels: can we afford to do them? Can we afford not to? Kuhn G Ann Emerg Med; 1986 Mar; 15(3):344-8. PubMed ID: 3946882 [TBL] [Abstract][Full Text] [Related]
15. The relationship of 5,5-diphenylhydantoin metabolism to the species-specific induction of gingival hyperplasia in the rat. Conard GJ; Haavik CO; Finger KF Arch Oral Biol; 1972 Feb; 17(2):311-21. PubMed ID: 4502048 [No Abstract] [Full Text] [Related]